REFERENCES
- Atkin NB, Baker MC. Chromosome study of five cancers of the prostate. Hum Genet 1985; 70: 359–364.
- Bergerheim U, Nordenskjöld M, Collins VP. Deletion mapping of human renal cell carcinoma. Cancer Res 1989; 49: 1390–1396.
- Bergerheim USR, Kunimi K, Collins VP, Ekman P. Deletion mapping of chromosomes 8, 10 and 16 in human prostatic carcinoma. Genes Chrom Cancer 1991; (in press).
- Bodmer WF, Bailey CJ, Bodmer J, Bussey HJR, Ellis A, Gorman P. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987; 328: 614–616.
- Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Krai A, Yeger H, Lewis WH, Jones C, Housman DE. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus! Cell 1990; 16: 509–520.
- Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 1990; 87: 8751–8755.
- Cavanee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphee AL, Strong LC, White RL. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 1983; 305: 779–784.
- Fearon ER, Kathleen RC, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, Vogelstein B. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990; 247: 49–56.
- Finlay CA, Hinds PW, Levine AJ. The p53 proto-oncogene can act as a suppression of transformation. Cell 1989; 57: 1083–1093.
- Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP. Human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986; 323: 643–646.
- Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GAP. Homozygous deletion in Wilms' tumours of a zinc-finger gene identified by chromosome jumping. Nature 1990; 343: 774–778.
- Gibas Z, Pontes JE, Sandberg AA. Chromosome rearrangements in a metastatic adenocarcinoma of the prostate. Cancer Genet Cytogenetic 1985; 16: 301–304.
- Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974; 111: 58–64.
- James CD, Carlbom E, Dumanski JP, Hansen MF, Nordenskjöld M, Collins VP, Cavanee WK. Clonal genomic alterations in glioma malignancy stages. Cancer Res 1988; 48: 5546–5555.
- Joseph LJ, LeBeau MM, Jamieson GA, Archarya S, Shows T. Molecular cloning, sequencing, and mapping of EGR2, a human early growth response gene encoding a protein with “zinc-binding finger” structure. Proc Natl Acad Sci USA 1988; 85: 7164–7168.
- Kidd KK, Bowcock AM, Schmidtke J, Track RK, Riccuti F, Hutchings G, Bale A, Pearson P, Willard HF. Report of the DNA committee and catalogs of cloned and mapped genes and DNA polymorphisms. Tenth International Workshop on Human Gene Mapping. Cytogenetic Cell Genet 1989; 51: 622–947.
- Klein G. The approaching era of the tumor suppressor genes. Science 1987; 228: 1539–1545.
- Knudsen AG. Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971; 68: 820–838.
- Kunimi K, Bergerheim USR, Larsson IL, Ekman P, Collins VP. Allelotyping of human prostatic adenocarcinom. Genomics 1991; (in press).
- Lee WH, Shew JY, Hong FD, Sery TW, Donoso LA. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 1987; 329: 642–645.
- Lundgren R, Kristoffersson U, Heim S, Mandahl N, Mittelman F. Multiple structural chromosome rearrangements including del (7p) and del (10q) in an adenocarcinoma of the prostate. Cancer Genet Cytogenet 1988; 35: 103–108.
- Mostofi FK, Sesterhenn I, Sobin LH. Histological typing of prostate tumors. WHO, International histological classification of tumors. No. 22, Geneva, 1980.
- Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Vogelstein B. Mutations in the p53 gene occur in diverse human tumor types. Nature 1989; 342: 705–708.
- Ponder B. Gene losses in human tumors. Nature 1988; 335: 400–402.
- Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smith AMM, Bosl JL. Genetic alterations during colorectal tumor development. N Engl J Med 1988; 319: 525–532.
- Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, White R. Allelotype of colorectal carcinoma. Science 1989; 244: 207–211.